Effect of Dolutegravir regimen against other regimens on some hematological parameters, CD4 count and viral load of people living with HIV infection in South Eastern Nigeria

BACKGROUND: Appropriate usage of highly active antiretroviral therapy (HAART) suppresses human immunodeficiency virus (HIV) replication. One of such HAART is dolutegravir (DTG) containing regimen which Nigeria included in her national protocol, as the preferred first-line option, with particularly f...

Descripción completa

Detalles Bibliográficos
Autores principales: Echefu, Stella N., Udosen, Joseph E., Akwiwu, Euphoria C., Akpotuzor, Josephine O., Obeagu, Emmanuel Ifeanyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4850
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681510/
https://www.ncbi.nlm.nih.gov/pubmed/38013350
http://dx.doi.org/10.1097/MD.0000000000035910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681510/
https://www.ncbi.nlm.nih.gov/pubmed/38013350
http://dx.doi.org/10.1097/MD.0000000000035910

Ejemplares similares